Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-292.29%
operating margin TTM
-308.99%
revenue TTM
41.55 Million
revenue per share TTM
0.49$
valuation ratios | |
|---|---|
| pe ratio | -17.31 |
| peg ratio | -5.09 |
| price to book ratio | 7.47 |
| price to sales ratio | 51.38 |
| enterprise value multiple | -16.85 |
| price fair value | 7.47 |
profitability ratios | |
|---|---|
| gross profit margin | 92.44% |
| operating profit margin | -308.99% |
| pretax profit margin | -290.71% |
| net profit margin | -292.29% |
| return on assets | -32.2% |
| return on equity | -48.74% |
| return on capital employed | -36.37% |
liquidity ratio | |
|---|---|
| current ratio | 10.64 |
| quick ratio | 10.64 |
| cash ratio | 1.36 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 47.88 |
| days of payables outstanding | 338.74 |
| cash conversion cycle | -290.86 |
| receivables turnover | 7.62 |
| payables turnover | 1.08 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.17 |
| debt equity ratio | 0.22 |
| long term debt to capitalization | 0.17 |
| total debt to capitalization | 0.18 |
| interest coverage | -35.05 |
| cash flow to debt ratio | -1.53 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.03 |
| cash per share | 2.52 |
| operating cash flow per share | -0.99 |
| free cash flow operating cash flow ratio | 1.05 |
| cash flow coverage ratios | -1.53 |
| short term coverage ratios | -19.28 |
| capital expenditure coverage ratio | -20.90 |
Frequently Asked Questions
When was the last time Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) reported earnings?
Fusion Pharmaceuticals Inc. (FUSN) published its most recent earnings results on 07-05-2024.
What is Fusion Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)'s trailing twelve months ROE is -48.74%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Fusion Pharmaceuticals Inc. (FUSN) currently has a ROA of -32.2%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did FUSN's net profit margin stand at?
FUSN reported a profit margin of -292.29% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is FUSN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.64 in the most recent quarter. The quick ratio stood at 10.64, with a Debt/Eq ratio of 0.22.